0 items USD 0.00Page not found
×
Error message
The page you requested does not exist. For your convenience, a search was performed using the query delveinsight juvenile idiopathic arthritis jia market insights epidemiology market forecast 2020.Your search for "" gave back 1527640 results.
Tyrosine Protein Kinase JAK1 - Pipeline Review, H1 2020 Summary Tyrosine Protein Kinase JAK1 (Janus Kinase 1 or JAK1 or EC 2.7.10.2) pipeline Target...
Catalog:
Global Markets Direct
January 2020
Price: USD 3,500.00
According to our Publisher latest study, the global Juvenile Idiopathic Arthritis Therapeutics market size was valued at USD million in 2022 and is...
Catalog:
GIR
February 2023
Price: USD 3,480.00
The global Polyarticular Juvenile Idiopathic Arthritis Drug market is projected to grow from US$ million in 2023 to US$ million by 2029, at a...
Catalog:
MRRPB5
August 2023
Price: USD 4,900.00
Summary HeyReport estimates that the Tumor Necrosis Factor (TNF) Inhibitor Drugs market size will grow from xxx Million USD in 2020 to xxxx Million...
Catalog:
HYR
July 2021
Price: USD 2,000.00
Systemic Idiopathic Juvenile Arthritis (Musculoskeletal) - Drugs in Development, 2021 Summary Systemic Idiopathic Juvenile Arthritis (Musculoskeletal...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) (Musculoskeletal) - Drugs in Development, 2021 Summary Systemic-Onset Juvenile...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Polyarticular Juvenile Idiopathic Arthritis (PJIA) (Musculoskeletal Disorders) - Drugs in Development, 2021 Summary Polyarticular Juvenile Idiopathic...
Catalog:
Global Markets Direct
April 2021
Price: USD 2,000.00
Systemic Idiopathic Juvenile Arthritis Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary Systemic Idiopathic...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
Systemic-Onset Juvenile Idiopathic Arthritis (Still Disease) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
Polyarticular Juvenile Idiopathic Arthritis (PJIA) Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players Summary...
Catalog:
Global Markets Direct
May 2022
Price: USD 2,000.00
Highlights The global Polyarticular Juvenile Idiopathic Arthritis Drug market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Arthritis is a very common disease but it is not well understood yet. Arthritis is basically joint pain or joint disease. Basically Juvenile...
Catalog:
MRRPB5
April 2023
Price: USD 2,900.00
Highlights The global Systemic Idiopathic Juvenile Arthritis Treatment market was valued at US$ million in 2022 and is anticipated to reach US$...
Catalog:
MRRPB5
March 2023
Price: USD 2,900.00
Highlights The global Juvenile Idiopathic Arthritis Therapeutics market was valued at US$ million in 2022 and is anticipated to reach US$ million by...
Catalog:
MRRPB5
January 2023
Price: USD 2,900.00
Tyrosine Protein Kinase JAK2 - Pipeline Review, H2 2020 Summary According to the recently published report 'Tyrosine Protein Kinase JAK2 -...
Catalog:
Global Markets Direct
July 2020
Price: USD 3,500.00
